Dr Agarwal's Hea

Who are the top shareholders of the Dr Agarwal's Hea?

The top shareholders of Dr Agarwal's Hea are primarily Foreign Institutional Investors (FIIs) with 60.62%, led by Hyperion Investments Pte Ltd at 23.17%. Dr. Athiya Agarwal is the largest individual shareholder at 5.99%, while mutual funds hold 3.84% and individual investors own 1.61%.

The top shareholders of Dr Agarwal's Hea include a mix of institutional and individual investors. The majority of the shares are held by Foreign Institutional Investors (FIIs), who own approximately 60.62% of the company. The highest public shareholder is Hyperion Investments Pte Ltd, holding 23.17%. Among individual stakeholders, Dr. Athiya Agarwal is the promoter with the highest holding at 5.99%. Additionally, mutual funds are represented by six schemes, collectively holding 3.84%. Individual investors account for 1.61% of the shares.

Has Dr Agarwal's Hea declared dividend?

No Dividend History Available

Who are the peers of the Dr Agarwal's Hea?

Dr Agarwal's Hea peers include Narayana Hrudaya, Global Health, and Aster DM Health, among others. Key insights show excellent management risk at Global Health and Narayana Hrudaya, with Aster DM Health having the highest 1-year return at 78.92%.

Peers: The peers of Dr Agarwal's Hea are Narayana Hrudaya, Global Health, Aster DM Health., Krishna Institu., Rainbow Child., Jupiter Life Lin, Health.Global, Kovai Medical, Yatharth Hospit.<BR><BR>Quality Snapshot: Excellent management risk is observed at Global Health, Jupiter Life Lin, and Narayana Hrudaya, while Average management risk is found at Aster DM Health., Yatharth Hospit., and the rest. Good growth is seen at Dr Agarwal's Hea, Narayana Hrudaya, and Global Health, while Below Average growth is noted at Aster DM Health., Krishna Institu., and the rest. Excellent capital structure is present at Global Health, Krishna Institu., and Yatharth Hospit., while Below Average capital structure is found at Aster DM Health., Health.Global, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Aster DM Health. at 78.92%, while the lowest is Jupiter Life Lin at 11.28%. Dr Agarwal's Hea does not have a 1-year return available for comparison. Additionally, Jupiter Life Lin and Health.Global have negative six-month returns.

What does Dr Agarwal's Hea do?

Dr Agarwal's Health Care Ltd is a mid-cap hospital company established in 2010, with recent quarterly net sales of ₹4,602 Cr and a net profit of ₹326 Cr as of March 2025. Key financial metrics include a P/E ratio of 160.00 and a market cap of ₹13,701 Cr.

Overview:<BR>Dr Agarwal's Health Care Ltd operates in the hospital industry and is categorized as a mid-cap company.<BR><BR>History:<BR>The company was incorporated in 2010 and commenced operations shortly thereafter. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 4,602 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 326 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 13,701 Cr (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 160.00 <BR>Industry P/E: 59 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.24 <BR>Return on Equity: 4.58% <BR>Price to Book: 7.34 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Dr Agarwal's Hea?

As of 24th July, Dr Agarwals Health Care Ltd has a market capitalization of 13,954.00 Cr, with recent net sales of 1,656.38 Cr and a net profit of 110.24 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Dr Agarwals Health Care Ltd has a market capitalization of 13,954.00 Cr, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 1,656.38 Cr, while the sum of Net Profit for the same period is 110.24 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 1,339.41 Cr and Total Assets totaling 2,716.13 Cr.

Is Dr Agarwal's Hea overvalued or undervalued?

As of September 12, 2025, Dr Agarwal's Healthcare is considered very expensive and overvalued with a PE ratio of 160.64, significantly higher than its peers, and a low ROE of 4.58%, making it not a compelling investment at its current price of 433.10.

As of 12 September 2025, the valuation grade for Dr Agarwal's Healthcare has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently deemed overvalued, with a PE ratio of 160.64, a Price to Book Value of 7.36, and an EV to EBITDA of 31.07. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Dr Agarwal's Healthcare stands out with a notably higher PE ratio than Max Healthcare, which has a PE of 95.48, and Apollo Hospitals, which is at 71.91. Additionally, the company's ROE is only 4.58%, which is considerably lower than the industry average, further reinforcing the overvaluation narrative. Despite a recent stock return of 1.55% over the past week, which slightly outperformed the Sensex's 1.48%, the overall valuation metrics suggest that Dr Agarwal's Healthcare is not a compelling investment at its current price of 433.10.

How has been the historical performance of Dr Agarwal's Hea?

Dr Agarwal's Hea has shown significant growth over the past three years, with net sales increasing from 1,017.98 Cr in Mar'23 to 1,711.00 Cr in Mar'25, and operating profit rising from 283.86 Cr to 502.40 Cr during the same period, alongside a substantial increase in total assets. Overall, the company demonstrates a solid performance trajectory with rising revenues and profits.

Answer:<BR>The historical performance of Dr Agarwal's Hea shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Dr Agarwal's Hea has demonstrated a strong upward trend in net sales, increasing from 1,017.98 Cr in Mar'23 to 1,711.00 Cr in Mar'25. Total operating income followed suit, rising from 1,017.98 Cr to 1,711.00 Cr during the same period. The company's total expenditure also grew, reaching 1,254.62 Cr in Mar'25, up from 747.63 Cr in Mar'23. Operating profit (PBDIT) saw a notable increase, climbing from 283.86 Cr in Mar'23 to 502.40 Cr in Mar'25. Profit before tax also improved, moving from 83.59 Cr in Mar'23 to 159.85 Cr in Mar'25, while profit after tax showed a slight fluctuation, peaking at 110.34 Cr in Mar'25 compared to 103.23 Cr in Mar'23. The consolidated net profit remained relatively stable, with a slight increase from 83.06 Cr in Mar'24 to 83.46 Cr in Mar'25. The company's total assets rose significantly from 1,769.72 Cr in Mar'23 to 3,639.60 Cr in Mar'25, reflecting robust growth in shareholder's funds and reserves. Cash flow from operating activities also improved, reaching 360.00 Cr in Mar'25, while cash flow from investing activities remained negative at -750.00 Cr, indicating ongoing investments. Overall, Dr Agarwal's Hea has shown a solid performance trajectory with increasing revenues and profits, alongside a growing asset base.

When is the next results date for Dr Agarwals Health Care Ltd?

The next results date for Dr Agarwals Health Care Ltd is February 3, 2026.

The next results date for Dr Agarwals Health Care Ltd is scheduled for February 3, 2026.

Should I buy, sell or hold Dr Agarwals Health Care Ltd?

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 17-Mar, Dr Agarwals Health Care Ltd's stock price is rising to Rs 426.45, following a trend reversal after five days of decline, driven by increased investor participation and strong financial performance. The stock outperformed its sector and reached an intraday high of Rs 438.4, indicating positive market sentiment.

As of 17-Mar, Dr Agarwals Health Care Ltd's stock price is rising, currently at Rs 426.45, reflecting an increase of Rs 4.5 or 1.07%. This upward movement follows a trend reversal after five consecutive days of decline. Today, the stock outperformed its sector by 0.52% and reached an intraday high of Rs 438.4, which is a 3.9% increase from its previous price.<BR><BR>The stock's rise can be attributed to several factors. Notably, there has been a significant increase in investor participation, with delivery volume on 16 March rising by 121.12% compared to the five-day average. This suggests a growing interest among investors, which often correlates with positive price movements. Additionally, the company's strong financial performance, including a low Debt to EBITDA ratio of 1.15 times and a healthy annual growth rate in net sales of 29.60%, supports a favorable outlook for the stock. The company has also consistently reported positive results over the last four quarters, with a notable growth in net profit of 19.57%.<BR><BR>Despite the stock trading below its moving averages, the combination of improved investor engagement and solid financial fundamentals appears to be driving the current rise in Dr Agarwals Health Care Ltd's stock price.

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 18-Mar, Dr Agarwals Health Care Ltd's stock price is Rs 429.70, having gained 1.4 (0.33%) recently, despite a year-to-date decline of 15.53%. The stock shows strong financial health and increased investor interest, contributing to its recent upward movement.

As of 18-Mar, Dr Agarwals Health Care Ltd's stock price is currently at Rs 429.70, reflecting a change of 1.4 (0.33%) upward. The stock has been gaining for the last two days, with a total return of 1.84% during this period. Additionally, the stock reached an intraday high of Rs 438, which represents a 2.26% increase.<BR><BR>Despite this recent upward movement, the stock has underperformed its sector by 0.97% today. Over the past week, it has seen a decline of 3.23%, and over the past month, it has fallen by 4.81%. Year-to-date, the stock is down 15.53%, although it has shown a positive return of 3.32% over the past year.<BR><BR>The stock's performance is supported by a significant increase in investor participation, with delivery volume rising by 254.11% compared to the five-day average. This indicates growing interest from investors, which could be contributing to the recent price increase.<BR><BR>On the fundamental side, the company has demonstrated strong financial health, with a low Debt to EBITDA ratio of 1.15 times and a healthy annual growth rate in net sales of 29.60%. Furthermore, the company has reported positive results for the last four consecutive quarters, with a notable growth in net profit of 19.57% and a PAT of Rs 63.43 crore, which has grown at 62.98%.<BR><BR>High institutional holdings at 65.84% suggest that knowledgeable investors are confident in the company's fundamentals, which may also be influencing the stock's recent price movements. Overall, while the stock has faced challenges in the short term, the combination of recent gains, strong financial performance, and increased investor participation is contributing to its current upward trajectory.

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 19-Mar, Dr Agarwals Health Care Ltd's stock price is at 424.00, down 2.21% after a trend reversal. Despite strong debt servicing and growth potential, the stock is underperforming against the Sensex and is in a bearish trend, trading below key moving averages.

As of 19-Mar, Dr Agarwals Health Care Ltd's stock price is falling, currently at 424.00, reflecting a decrease of 9.6 points or 2.21%. This decline follows a trend reversal after two consecutive days of gains. The stock has underperformed compared to the benchmark Sensex, which has fallen by 2.40% over the past week, while Dr Agarwals has dropped by 2.73%. <BR><BR>Today, the stock reached an intraday low of Rs 416.55, marking a significant decline of 3.93%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The broader sector of Hospital & Healthcare Services has also experienced a decline of 2.8%, contributing to the negative sentiment surrounding the stock.<BR><BR>Despite some positive factors, such as a strong ability to service debt and healthy long-term growth in net sales and profits, the current market conditions and recent performance have led to the stock's downward movement. The rising investor participation, with a notable increase in delivery volume, suggests some interest, but it has not been sufficient to counteract the overall decline in price.

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 20-Mar, Dr Agarwals Health Care Ltd's stock price is at 423.50, showing a slight increase but a downward trend overall, with declines of 0.63% over the past week and 5.15% over the past month. Despite this, the company has strong fundamentals, including a low Debt to EBITDA ratio and healthy growth in net sales and profit, indicating potential for stabilization or recovery.

As of 20-Mar, Dr Agarwals Health Care Ltd's stock price is currently at 423.50, reflecting a slight increase of 0.2 (0.05%). Despite this minor rise, the stock has shown a downward trend over various periods. Over the past week, it has underperformed with a decline of 0.63%, and over the past month, it has decreased by 5.15%. Year-to-date, the stock has fallen by 16.75, which is significantly more than the Sensex's decline of 12.54% in the same timeframe.<BR><BR>The stock's performance today indicates it has underperformed its sector by 0.51%. Additionally, it is trading below its moving averages across all time frames, including 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bearish trend. <BR><BR>However, there are positive indicators that may support a stabilization or potential recovery in the future. The company has a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.15 times. Furthermore, it has demonstrated healthy long-term growth, with net sales increasing at an annual rate of 29.60% and net profit growing by 19.57%. The company has reported positive results for the last four consecutive quarters, with a significant increase in profit after tax and net sales reaching their highest levels.<BR><BR>Moreover, the stock has seen a rise in investor participation, with delivery volume increasing by 0.08% against the 5-day average. High institutional holdings at 65.84% suggest that more sophisticated investors are backing the company, which could provide some stability.<BR><BR>In summary, while Dr Agarwals Health Care Ltd is currently experiencing a slight rise in stock price, the overall trend indicates a decline over the past weeks and months, influenced by its performance relative to benchmarks and moving averages, despite strong fundamentals and positive growth indicators.

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 23-Mar, Dr Agarwals Health Care Ltd's stock is at 418.00, down 1.47%, with significant losses and underperformance relative to the market. The stock is trading below key moving averages, and investor interest has decreased, although the company shows strong long-term growth potential.

As of 23-Mar, Dr Agarwals Health Care Ltd's stock price is falling, currently at 418.00, which reflects a decrease of 6.25 (-1.47%). The stock opened the day with a significant loss of 3.62% and reached an intraday low of Rs 408.9. This decline is compounded by the overall performance of the Hospital & Healthcare Services sector, which has fallen by 2.37%. <BR><BR>In terms of stock performance relative to the benchmark, Dr Agarwals has underperformed over various periods, including a 1-week decline of 0.94% compared to a 3.72% drop in the Sensex, and a 1-month decline of 5.47% against a 12.72% decrease in the benchmark. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>Investor participation has also decreased, with delivery volume dropping by 50.73% compared to the 5-day average, suggesting reduced interest among investors. Despite these negative indicators, the company maintains a strong ability to service debt and has shown healthy long-term growth in net sales and profits, which may provide some support for the stock in the future. However, the current market conditions and sector performance are contributing to the stock's decline.

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 24-Mar, Dr Agarwals Health Care Ltd's stock price is at 417.65, down 1.5 points or 0.36%, with a year-to-date decline of 17.90%. The stock is underperforming due to decreased investor participation and is trading below its moving averages, indicating a bearish trend despite some positive long-term growth factors.

As of 24-Mar, Dr Agarwals Health Care Ltd's stock price is currently at 417.65, reflecting a decrease of 1.5 points or 0.36%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 1.84% during this period. Despite opening with a gain of 5.17% today and reaching an intraday high of Rs 440.8, the stock's overall performance has been negatively impacted by a significant drop in investor participation, with delivery volume falling by 39.63% compared to the five-day average.<BR><BR>In terms of broader performance, the stock has shown a year-to-date decline of 17.90%, which is worse than the benchmark Sensex's decline of 13.09%. Additionally, the stock is trading below its moving averages across various time frames, indicating a bearish trend. While the hospital and healthcare services sector has gained by 2.48%, Dr Agarwals Health Care Ltd has underperformed its sector by 2.99%. <BR><BR>Despite some positive factors, such as strong debt servicing capability and healthy long-term growth in net sales and profits, the immediate market sentiment appears to be negative, contributing to the stock's current decline.

Why is Dr Agarwals Health Care Ltd falling/rising?

As of 25-Mar, Dr Agarwals Health Care Ltd's stock price is at Rs 413.70, reflecting a decline of 0.95%. Despite strong fundamentals, the stock has underperformed significantly, dropping 18.68% year-to-date, with reduced investor interest contributing to its recent price weakness.

As of 25-Mar, Dr Agarwals Health Care Ltd's stock price is falling, currently at Rs 413.70, which reflects a decrease of Rs 3.95 or 0.95%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 2.49% during this period. Over the past week, the stock has decreased by 4.59%, while its performance over the last month shows a decline of 8.25%. Year-to-date, the stock has dropped 18.68%, significantly underperforming compared to the Sensex, which has only fallen by 11.67% in the same timeframe.<BR><BR>Despite opening with a gain of 2.01% today and reaching an intraday high of Rs 426.05, the overall trend indicates weakness, as the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 54.79% compared to the 5-day average, indicating reduced trading interest.<BR><BR>While the company has demonstrated strong fundamentals, such as a low Debt to EBITDA ratio and consistent growth in net sales and profits, these positive factors have not been sufficient to counteract the recent negative price movements and overall market sentiment. The healthcare sector has seen gains, but Dr Agarwals Health Care Ltd has not benefited from this trend, leading to its current decline in stock price.

Which are the latest news on Dr Agarwal's Hea?